Annual Revenue
$314.00 K
-$1.46 M-82.28%
December 31, 2023
Summary
- As of February 25, 2025, VRDN annual revenue is $314.00 thousand, with the most recent change of -$1.46 million (-82.28%) on December 31, 2023.
- During the last 3 years, VRDN annual revenue has fallen by -$736.00 thousand (-70.10%).
- VRDN annual revenue is now -96.26% below its all-time high of $8.39 million, reached on December 31, 2018.
Performance
VRDN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$86.00 K
+$14.00 K+19.44%
September 30, 2024
Summary
- As of February 25, 2025, VRDN quarterly revenue is $86.00 thousand, with the most recent change of +$14.00 thousand (+19.44%) on September 30, 2024.
- Over the past year, VRDN quarterly revenue has increased by +$14.00 thousand (+19.44%).
- VRDN quarterly revenue is now -98.20% below its all-time high of $4.78 million, reached on March 31, 2018.
Performance
VRDN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$302.00 K
+$14.00 K+4.86%
September 30, 2024
Summary
- As of February 25, 2025, VRDN TTM revenue is $302.00 thousand, with the most recent change of +$14.00 thousand (+4.86%) on September 30, 2024.
- Over the past year, VRDN TTM revenue has dropped by -$45.00 thousand (-12.97%).
- VRDN TTM revenue is now -96.91% below its all-time high of $9.79 million, reached on June 30, 2018.
Performance
VRDN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VRDN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.3% | +19.4% | -13.0% |
| 3 y3 years | -70.1% | +19.4% | -13.0% |
| 5 y5 years | -96.3% | +19.4% | -13.0% |
VRDN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.4% | at low | -92.8% | +19.4% | -89.8% | +4.9% |
| 5 y | 5-year | -93.0% | at low | -94.1% | +59.3% | -93.9% | +4.9% |
| alltime | all time | -96.3% | at low | -98.2% | +59.3% | -96.9% | +4.9% |
Viridian Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $86.00 K(+19.4%) | $302.00 K(+4.9%) |
| Jun 2024 | - | $72.00 K(0.0%) | $288.00 K(0.0%) |
| Mar 2024 | - | $72.00 K(0.0%) | $288.00 K(-8.3%) |
| Dec 2023 | $314.00 K(-82.3%) | $72.00 K(0.0%) | $314.00 K(-9.5%) |
| Sep 2023 | - | $72.00 K(0.0%) | $347.00 K(-76.4%) |
| Jun 2023 | - | $72.00 K(-26.5%) | $1.47 M(-11.1%) |
| Mar 2023 | - | $98.00 K(-6.7%) | $1.65 M(-6.7%) |
| Dec 2022 | $1.77 M(-40.2%) | $105.00 K(-91.2%) | $1.77 M(-5.8%) |
| Sep 2022 | - | $1.20 M(+366.8%) | $1.88 M(+110.4%) |
| Jun 2022 | - | $256.00 K(+18.5%) | $894.00 K(-48.3%) |
| Mar 2022 | - | $216.00 K(+0.9%) | $1.73 M(-41.7%) |
| Dec 2021 | $2.96 M(+182.2%) | $214.00 K(+2.9%) | $2.96 M(+5.7%) |
| Sep 2021 | - | $208.00 K(-80.9%) | $2.80 M(+8.0%) |
| Jun 2021 | - | $1.09 M(-24.9%) | $2.60 M(+55.1%) |
| Mar 2021 | - | $1.45 M(+2587.0%) | $1.67 M(+59.3%) |
| Dec 2020 | $1.05 M(-76.5%) | $54.00 K(-67.9%) | $1.05 M(-59.2%) |
| Jun 2020 | - | $168.00 K(-79.7%) | $2.57 M(-47.7%) |
| Mar 2020 | - | $828.00 K(-5.9%) | $4.92 M(+10.2%) |
| Dec 2019 | $4.46 M(-46.8%) | $880.00 K(+26.6%) | $4.46 M(+10.0%) |
| Sep 2019 | - | $695.00 K(-72.4%) | $4.06 M(-5.8%) |
| Jun 2019 | - | $2.51 M(+575.8%) | $4.31 M(+8.4%) |
| Mar 2019 | - | $372.00 K(-21.8%) | $3.97 M(-52.6%) |
| Dec 2018 | $8.39 M | $476.00 K(-49.6%) | $8.39 M(-7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $944.00 K(-56.7%) | $9.10 M(-7.0%) |
| Jun 2018 | - | $2.18 M(-54.4%) | $9.79 M(+17.6%) |
| Mar 2018 | - | $4.78 M(+301.3%) | $8.32 M(+108.0%) |
| Dec 2017 | $4.00 M(+20.0%) | $1.19 M(-26.9%) | $4.00 M(+12.2%) |
| Sep 2017 | - | $1.63 M(+127.2%) | $3.57 M(+26.3%) |
| Jun 2017 | - | $718.00 K(+55.4%) | $2.83 M(-5.2%) |
| Mar 2017 | - | $462.00 K(-38.9%) | $2.98 M(-10.7%) |
| Dec 2016 | $3.34 M(+31.5%) | $756.00 K(-15.0%) | $3.34 M(+3.0%) |
| Sep 2016 | - | $889.00 K(+1.7%) | $3.24 M(+13.6%) |
| Jun 2016 | - | $874.00 K(+6.8%) | $2.85 M(+5.2%) |
| Mar 2016 | - | $818.00 K(+24.1%) | $2.71 M(+6.8%) |
| Dec 2015 | $2.54 M(-41.3%) | $659.00 K(+31.5%) | $2.54 M(+0.2%) |
| Sep 2015 | - | $501.00 K(-31.7%) | $2.54 M(-24.0%) |
| Jun 2015 | - | $734.00 K(+13.8%) | $3.33 M(-13.9%) |
| Mar 2015 | - | $645.00 K(-1.5%) | $3.88 M(-10.3%) |
| Dec 2014 | $4.32 M(+0.1%) | $655.00 K(-49.7%) | $4.32 M(-9.1%) |
| Sep 2014 | - | $1.30 M(+2.1%) | $4.76 M(+7.2%) |
| Jun 2014 | - | $1.27 M(+16.8%) | $4.44 M(+4.0%) |
| Mar 2014 | - | $1.09 M(+0.1%) | $4.27 M(-1.1%) |
| Dec 2013 | $4.32 M(-2.0%) | $1.09 M(+10.8%) | $4.32 M(+33.8%) |
| Sep 2013 | - | $983.60 K(-10.8%) | $3.23 M(+43.9%) |
| Jun 2013 | - | $1.10 M(-3.2%) | $2.24 M(+96.8%) |
| Mar 2013 | - | $1.14 M | $1.14 M |
| Dec 2012 | $4.41 M | - | - |
FAQ
- What is Viridian Therapeutics annual revenue?
- What is the all time high annual revenue for Viridian Therapeutics?
- What is Viridian Therapeutics annual revenue year-on-year change?
- What is Viridian Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly revenue year-on-year change?
- What is Viridian Therapeutics TTM revenue?
- What is the all time high TTM revenue for Viridian Therapeutics?
- What is Viridian Therapeutics TTM revenue year-on-year change?
What is Viridian Therapeutics annual revenue?
The current annual revenue of VRDN is $314.00 K
What is the all time high annual revenue for Viridian Therapeutics?
Viridian Therapeutics all-time high annual revenue is $8.39 M
What is Viridian Therapeutics annual revenue year-on-year change?
Over the past year, VRDN annual revenue has changed by -$1.46 M (-82.28%)
What is Viridian Therapeutics quarterly revenue?
The current quarterly revenue of VRDN is $86.00 K
What is the all time high quarterly revenue for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly revenue is $4.78 M
What is Viridian Therapeutics quarterly revenue year-on-year change?
Over the past year, VRDN quarterly revenue has changed by +$14.00 K (+19.44%)
What is Viridian Therapeutics TTM revenue?
The current TTM revenue of VRDN is $302.00 K
What is the all time high TTM revenue for Viridian Therapeutics?
Viridian Therapeutics all-time high TTM revenue is $9.79 M
What is Viridian Therapeutics TTM revenue year-on-year change?
Over the past year, VRDN TTM revenue has changed by -$45.00 K (-12.97%)